Synthesis process of hydrocortisone hemisuccinate
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- 安徽海洋药业有限公司
- Publication Date
- 2021-01-15
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1
Abstract
Description
technical field
[0001] The invention relates to the field of chemical drug synthesis, in particular to a synthesis process of hydrocortisone hemisuccinate. Background technique
[0002] Hydrocortisone hemisuccinate is an esterification product of hydrocortisone, which belongs to adrenal glucocorticoid drugs, and has anti-inflammatory, anti-shock and anti-allergic effects. Clinically, it is mainly used for adrenal glucocorticoid insufficiency, allergic diseases such as acute bronchial asthma, bronchitis, and acute ophthalmia, etc. It is also used for high fever caused by some serious infections. Compared with hydrocortisone, its Longer half-life, longer duration of curative effect. In addition, hydrocortisone hemisuccinate can also be used for the preparation of clinical water-soluble corticosteroid hydrocortisone sodium succinate except supplying clinical application, so successfully synthesized hydrocortisone hemisuccinate and improve its output namely appears to be parti...